Radioligand Therapy (RLT) in Prostate Cancer: From Innovation to Implementation
Radioligand Therapy (RLT) in Prostate Cancer: From Innovation to Implementation
Recording from June 23, 2023
Speakers: Jean-Mathieu Beauregard, Kim Chi, Fred Saad
Objectives:
- implement best practices for RLT program implementation
- advocate for RLT resources and infrastructure
- engage in early Canadian experience and future perspectives in RLT
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
This program has received financial support from Novartis in the form of an educational grant.